Navigation

Researchers at UCD

researcher

Malcolm Robin Kell

Consultant Surgeon & Clinical Professor

School of Medicine
Breastcheck, 36 Eccles St
Dublin 7, Ireland.

Tel: 018828102
Email: malcolm.kell@cancerscreening.ie

Biography

Malcolm Kell has worked as a consultant surgeon and senior lecturer within the national breast screening program in the Mater Misericordiae University Hospital since November 2005. This followed completion of surgical oncology training in Fox Chase Cancer Center, Philadelphia, under the direction of Dr Monica Morrow. This fellowship was designed to prepare for a leadership role in breast cancer care in an academic setting.

Professor Kell is trained in the multidisciplinary surgical management of cancer. Clinical and research interests have focused to develop accelerated care pathways to facilitate and expedite patient care. Research has explored methods to enhance patients' aesthetic outcome following breast conservation and applied this to clinical practice. The sum of these clinical protocols is to apply best evidence practice, to ensure patients have not only optimum cancer outcome but also excellent survivorship. Professor Kell is also involved in research focused on improving outcome following aesthetic breast surgery.

Numerous research publications and projects have helped to develop cancer care within Ireland. Several full time research fellows are currently working under the Direction of Professor Kell, Dr Amanda McCann and Professor William Gallagher in UCD. Malcolm has numerous national and international publications, has won the Bennet medal, delivered the 30th Millin lecture in RCSI, the 2014 St Luke¿s Lecture and recently has developed the Surgical Oncology Research Appeal through the Mater Foundation. Dr Roisin Dolan won the British Journal of Surgery prize for best paper at the British Association of Surgical Oncology, London 2010, under the direction of Mr Kell and Professor Liam Gallagher.

 

 

 

 

 

 

Professional

Honours and Awards

Year: 2008.
Title: Surgical Oncology Reseach Appeal
Year: 2004.
Title: Society of Surgical Oncology Fellow
Year: 1998.
Title: Surgical Immunology Fellow
Year: 2003.
Title: Bennett Medal
Year: 2007.
Title: Millin Lecture

Associations

Association: American Society of Clinical Oncology, Function/Role: Member and Committee
Association: British Association of Surgical Oncology, Function/Role: Member
Association: Society of Surgical Oncology, Function/Role: member
Association: American Societof Clinical Oncology, Function/Role: Member
     

Conference Contributions

Malcolm R Kell; (2011) Organising committee. [Chaired Session], ASCO Breast Cancer Symposium, San Francisco, USA , 08-SEP-11 - 10-SEP-11.
Malcolm R Kell (2012) breast research and practice forum. [Chaired Session], American society of clinical oncology breast cancer symposium, San Francisco , 06-SEP-12 - 09-SEP-12.
Organising Committe (2012) Breast cancer synposium and research forum. [Conference Organising Committee Member], American Society of Clinical oncology breast cancer symposium, San Francisco , 06-SEP-12 - 09-SEP-12.

Committees

Committee : Researh and Ethics
Committee : Symptomatic Breast Cancer
Committee : Human Research Ethics Committee - Sciences
             

Publications

 

Book Chapters

Malcolm Kell Monica Morrow; (2006) 'Multifocal, multicentric, and bilateral breast cancer' In: Malcolm Kell Monica Morrow; (eds). Breast cancer. USA: Decker. [Details]
M. R. Kell, H. P. Redmond; (2003) 'Experimental models of source control' In: M. R. Kell, H. P. Redmond; (eds). Source Control: A guide to management of surgical infections. New York: Springer. [Details]
 

Peer Reviewed Journals

Weiner-Gorzel K, Dempsey E, Milewska M, McGoldrick A, Toh V, Walsh A, Lindsay S, Gubbins L, Cannon A, Sharpe D, O'Sullivan J, Murphy M, Madden SF, Kell M, McCann A, Furlong F (2015) 'Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells'. Cancer medicine, 4 (5):745-758. [DOI] Link to full text [Details]
Joyce DP, Manning A;Carter M;Hill AD;Kell MR;Barry M (2015) 'Meta-analysis to determine the clinical impact of axillary lymph node dissection in the treatment of invasive breast cancer'. Breast Cancer Research and Treatment, 153 (2):235-240. [DOI] [Details]
Sharma S, Barry M;Gallagher DJ;Kell M;Sacchini V (2015) 'An overview of triple negative breast cancer for surgical oncologists'. Surgical Oncology, 24 (3):276-283. [DOI] [Details]
Kell MR, Sharma S (2015) 'Minimally invasive, maximal outcomes in breast surgery'. Surgeon, . [DOI] [Details]
Sharma SD, Barry M;O'Reilly EA;Kell MR (2015) 'Surgical management of lobular carcinoma from a national screening program: a retrospective analysis'. European Journal of Surgical Oncology, 41 (1):79-85. [DOI] [Details]
Kell MR (2014) 'Breast cancer: from Halsted to Harney'. Medicine, . [DOI] [Details]
O Leary PC, Penny SA, Dolan RT, Kelly CM, Madden SF, Rexhepaj E, Brennan DJ, McCann AH, Pontén F, Uhlén M, Zagozdzon R, Duffy MJ, Kell MR, Jirström K, Gallagher WM (2013) 'Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer'. BMC Cancer, 13 . [DOI] [Details]
Harris E, Barry M, Kell MR (2013) 'Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival'. Annals of Surgical Oncology, 20 (9):2828-2834. [DOI] [Details]
Barry M, Kell MR (2013) 'Influence of tumour biology on the surgical management of triple-negative breast cancer'. British Journal of Surgery, 100 (9):1126-1127. [DOI] [Details]
Harris E, Barry M, Kell MR (2013) 'Supporting trials for primary tumor resection in stage IV breast cancer is paramount'. Annals of Surgical Oncology, 20 (9):3151-3152. [DOI] [Details]
Conrick-Martin I., Kell MR., Buggy DJ (2012) 'Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function'. Journal of Clinical Anesthesia, 24 (1):3-7. [Details]
Barry M, Kell MR. (2012) 'Re-evaluating the role of axillary lymph node dissection in screen-detected breast cancer patients'. The breast journal, . [Details]
Barry M, Kell MR. (2012) 'Breast cancer: can axillary lymph node dissection be avoided?'. European Journal of Surgical Onocology, . [Details]
Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ (2012) 'Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype'. Breast Cancer Research and Treatment, 133 (3):831-841. [DOI] [Details]
Barry M, Kell MR (2012) 'Breast cancer: can axillary lymph node dissection be avoided?'. Surgical Oncology, 38 (1):6-7. [DOI] [Details]
Rajpal, R,Dowling, P,Meiller, J,Clarke, C,Murphy, WG,O'Connor, R,Kell, M,Mitsiades, C,Richardson, P,Anderson, KC,Clynes, M,O'Gorman, P; (2011) 'A novel panel of protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patients'. Proteomics, 11 :1391-1402. [DOI] [Details]
Barry M, Kell MR; (2011) 'Radiotherapy and breast reconstruction: a meta-analysis'. Breast Cancer Research and Treatment, 127 (1):15-22. [DOI] [Details]
Burke JP, Barry M, Kell MR; (2011) 'More on screening mammography'. Then New England Journal of Medicine, 364 (3):281-21. [DOI] [Details]
Robertson IJ, Hand F, Kell MR. (2011) 'FDG-PET/CT in the staging of local/regional metastases in breast cancer'. The breast journal, . [Details]
Donatello, S,Hudson, L,Cottell, DC,Blanco, A,Aurrekoetxea, I,Shelly, MJ,Dervan, PA,Kell, MR,Stokes, M,Hill, ADK,Hopkins, AM; (2011) 'An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models'. Journal of Experimental and Clinical Cancer Research, 30 . [DOI] [Details]
Barry M, Kell MR; (2010) 'Gene-expression profiling in breast cancer: bespoke cancer therapy or more fiction than science?'. Medicine, 179 (4):479-481. [DOI] [Details]
Kell MR.; (2010) 'Magnetic resonance mammography'. British Medical Journal, 341 (5513):10. [Details]
Kell MR, Burke JP, Barry M, Morrow M.; (2010) 'Outcome of axillary staging in early breast cancer: a meta-analysis'. Breast Cancer Research and Treatment, 120 (2):441-447. [Details]
Dolan RT, Butler JS, Kell MR, Gorey TF, Stokes MA; (2010) 'Nipple discharge and the efficacy of duct cytology in evaluating breast cancer risk'. Surgeon, 8 (5):252-258. [DOI] [Details]
Barry, M,Kell, MR; (2009) 'Enhancing the Adjuvant Treatment of Hormone Receptor Positive Breast Cancer'. The breast journal, 15 :194-198. [DOI] [Details]
Dunne C, Burke JP, Morrow M, M. R. Kell; (2009) 'Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ'. Clinical oncology, . [Details]
Burke JP, Power C, Gorey TF, Flanagan F, Kerin MJ, Kell MR; (2008) 'A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer'. Surgical Oncology, 34 (2):149-153. [DOI] [Details]
J. P. Burke,C. Power, T. F. Gorey,F. Flanagan,M. J. Kerin, M. R. Kell. ; (2008) 'Screen detected breast cancer is associated with a better predicted outcome independent of risk factors at presentation'. european journal of surgical oncology, . [Details]
Sweeney KJ, Kell MR, Aziz NA, Prunty N, Holloway P, Kennedy M, Flanagan F, Kerin MJ; (2007) 'The clinical and pathological differences in prevalent round screen-detected and symptomatic invasive breast cancer'. Irish Medical Journal, 100 (8):550-552. [Details]
M. R. Kell, J. P. Burke. ; (2007) 'Breast surgery in BRCA mutation breast cancer'. British Medical Journal, 334 :437-438. [Details]
J. P. Burke,C. Power, T. F. Gorey,F. Flanagan,M. J. Kerin, M. R. Kell. ; (2007) 'Screen detected breast cancer is associated with a better predicted outcome independent of risk factors at presentation'. European Journal of Surgical Oncology, . [Details]
M. R. Kell, N. Joseph, D. Ridge, E. Sigurdson. ; (2007) 'PET/CT imaging in patients undergoing sentinel node biopsy fro melanoma'. European Journal of Surgical Oncology, . [Details]
Kell, MR; ; (2007) 'Specialist centres - US cancer centres show the way'. British Medical Journal, 334 :550-550. [Details]
Kell, MR; Burke, JP; ; (2007) 'Management of breast cancer in women with BRCA gene mutation - Breast conservation surgery is safe in selected women when combined with adjuvant therapy'. British Medical Journal, 334 :437-438. [Details]
Moran, CJ,Kell, MR,Flanagan, FL,Kennedy, M,Gorey, TF,Kerin, MJ; (2007) 'Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients'. American Journal of Surgery, 194 (NA):172-175. [DOI] [Details]
Burke JP, Power C, Gorey TF, Flanagan F, Kerin MJ, Kell MR; (2007) 'A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer'. European Journal of Surgical Oncology, . [Details]
Kell MR; (2007) 'US cancer centres show the way'. BMJ (Clinical research ed.), 334 (7593). [DOI] [Details]
Kell MR, Burke JP; (2007) 'Management of breast cancer in women with BRCA gene mutation'. BMJ (Clinical research ed.), 334 (7591):437-438. [DOI] [Details]
Conneely, JB; Kell, MR; Boran, S; Flanagan, F; Kerin, MJ; ; (2006) 'A case of bilateral breast cancer with Peutz-Jeghers syndrome'. Ejso, 32 (1):121-122. [Details]
M. R. Kell, M. Morrow. ; (2006) 'Surgical aspects of inflammatory breast cancer'. Breast Disease, 22 (1):67-73. [Details]
Moran CJ, Kell MR, Kerin MJ; (2005) 'The role of sentinel lymph node biopsy in ductal carcinoma in situ'. Surgical Oncology, 31 (10):1105-1111. [DOI] [Details]
Kell MR, Morrow M; (2005) 'An adequate margin of excision in ductal carcinoma in situ'. BMJ (Clinical research ed.), 331 (7520):789-790. [DOI] [Details]
Sweeney KJ, Kell MR, Ravi N, Reynolds JV; (2005) 'Major upper gastrointestinal surgery is associated with an antigen-dependent proinflammatory T cell response'. British Journal of Surgery, 92 (8):989-995. [DOI] [Details]
Smith FM, Coffey JC, Kell MR, O'Sullivan M, Redmond HP, Kirwan WO; (2005) 'A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch'. Colorectal Disease, 7 (6):563-570. [DOI] [Details]
Kell MR, Power CP; (2005) 'Adjuvant trastuzumab for breast cancer: assessing HER2/neu status incurs more costs for treatment'. BMJ (Clinical research ed.), 331 (7526). [DOI] [Details]
Kell MR, Morrow M; (2005) 'Surgical aspects of inflammatory breast cancer'. Breast Disease, 22 :67-73. [Details]
Kell, MR,Sweeney, KJ,Moran, CJ,Flanagan, F,Kerin, MJ,Gorey, TF; (2004) 'Minimally invasive parathyroidectomy with operative ultrasound localization of the adenoma'. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 18 :1097-1098. [DOI] [Details]
Moran, C, Kell, MR, Flanagan, F, Kennedy, M, Corrigan, T, Gorey, T, Kerin, MJ, ; (2004) 'Prophylactic sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients'. British Journal of Surgery, 91 (NA):133-133. [Details]
Kell, MR, Beddy, D, O'Toole, PJ, Conneely, J, Winter, DC, Watson, W, Fitzpatrick, JM, Kerin, M, ; (2004) 'Systemic T cell interleukin 2 production correlates with disease stage in breast cancer patients'. British Journal of Surgery, 91 (9):1227-1227. [Details]
Kell, MR, Kerin, MJ, ; (2004) 'The value of axillary lymphadenectomy (vol 29, pg 701, 2003)'. European Journal of Surgical Oncology, 30 (1):90-90. [Details]
Kell, MR, Sweeney, KJ, Moran, CJ, Flanagan, F, Kerin, MJ, Gorey, TF, ; (2004) 'Minimally invasive parathyroidectomy with operative ultrasound localization of the adenoma'. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 18 (7):1097-1098. [Details]
Moran, C; Kell, MR; Flanagan, F; Kennedy, M; Corrigan, T; Gorey, T; Kerin, MJ; ; (2004) 'Prophylactic sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients'. British Journal of Surgery, 91 (NA):133-133. [Details]
Kell MR, Kerin MJ; (2004) 'Sentinel lymph node biopsy'. BMJ (Clinical research ed.), 328 (7452):1330-1331. [DOI] [Details]
Winter DC, Murphy A, Kell MR, Shields CJ, Redmond HP, Kirwan WO; (2004) 'Perioperative topical nitrate and sphincter function in patients undergoing transanal stapled anastomosis: a randomized, placebo-controlled, double-blinded trial'. Diseases of the Colon and Rectum, 47 (5):697-703. [DOI] [Details]
Power CP, Wang JH, Manning B, Kell MR, Aherne NJ, Wu QD, Redmond HP; (2004) 'Bacterial lipoprotein delays apoptosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2'. Journal of Immunology, 173 (8):5229-5237. [Details]
Kell MR, Power K, Winter DC, Power C, Shields C, Kirwan WO, Redmond HP; (2003) 'Predicting outcome after appendicectomy'. Medicine, 172 (2):63-65. [Details]
Kell, MR, Conneely, J, O'Toole, PJ, Winter, DC, Beddy, D, Watson, W, Fitzpatrick, JM, Kerin, M, ; (2003) 'T-cell function correlates with oncological status in breast cancer'. British Journal of Surgery, 90 (NA):46-46. [Details]
Kelly, MR, Kerin, MJ, ; (2003) 'The value of axillary lymphadenectomy'. European Journal of Surgical Oncology, 29 (9):701-702. [Details]
Kell, MR; Sweeney, K; Beddy, D; Connelly, J; Winter, DC; Watson, RGW; Fitzpatrick, JM; Kerin, M; ; (2003) 'Systemic T-cells are primed for a tumour permissive phenotype in breast cancer patients'. British Journal of Surgery, 90 (5):602-603. [Details]
Kell, MR; Beddy, D; Conneely, J; O'Toole, PJ; Winter, DC; Watson, W; Fitzpatrick, JM; Kerin, MJ; ; (2003) 'T-cell function correlates with oncological status and disease stage in breast cancer'. Breast Cancer Research and Treatment, 82 (NA):114-114. [Details]
Sweeney KJ, Kell MR, Coates C, Murphy T, Reynolds JV; (2003) 'Serum antigen(s) drive the proinflammatory T cell response in acute pancreatitis'. British Journal of Surgery, 90 (3):313-319. [DOI] [Details]
Kell MR, Barry BD, Redmond HP; (2003) 'Systemic inflammatory response syndrome: a new direction?'. Medicine, 172 (1):7-8. [Details]
Sweeney KJ, Evoy D, Sultan S, Coates C, Moore DJ, Shanik DG, Kell MR, Reynolds JV; (2002) 'Endovascular approach to abdominal aortic aneurysms limits the postoperative systemic immune response'. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 23 (4):303-308. [DOI] [Details]
Kell MR, Aherne NJ, Coffey C, Power CP, Kirwan WO, Redmond HP; (2002) 'Emergency surgeon-performed hepatobiliary ultrasonography'. British Journal of Surgery, 89 (11):1402-1404. [DOI] [Details]
Barry BD, Kell MR, Redmond HP; (2002) 'Tumor lysis syndrome following endoscopic radiofrequency interstitial thermal ablation of colorectal liver metastases'. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 16 (7). [DOI] [Details]
Kell MR, Shelley O, Mannick JA, Guo Z, Lederer JA; (2000) 'A central role for CD95 (Fas) in T-cell reactivity after injury'. Surgery - Elsevier, 128 (2):159-164. [DOI] [Details]
Kell MR, Winter DC, O'Sullivan GC, Shanahan F, Redmond HP; (2000) 'Biological behaviour and clinical implications of micrometastases'. British Journal of Surgery, 87 (12):1629-1639. [DOI] [Details]
Kell MR, O'Connell PR; (2000) 'Femoral nerve neuropraxia after abdominoperineal resection'. Diseases of the colon and rectum, 43 (5). [Details]
Kavanagh EK, Kell MR, Goebel A, Soberg CC, Mannick JA, Lederer JA; (1999) 'Interleukin 10 is not essential for survival or for modulating T-cell function after injury'. Surgery - Elsevier, 126 (2):456-462. [Details]
Fanning NF, Kell MR, Shorten GD, Kirwan WO, Bouchier-Hayes D, Cotter TG, Redmond HP; (1999) 'Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation'. Shock, 11 (3):167-174. [Details]
Kell MR, Kavanaugh EG, Goebel A, Soberg CC, Lederer JA; (1999) 'Injury primes the immune system for an enhanced and lethal T-cell response against bacterial superantigen'. Shock, 12 (2):139-144. [Details]
Kell MR, Winter DC, Ryan D, Lynch M, Brew B, Rajpal P, Kirwan WO, Redmond HP; (1999) 'Nitric oxide synthetase and Helicobacter pylori in patients undergoing appendicectomy'. British Journal of Surgery, 86 (12):1-1542. [DOI] [Details]

Other Journals

Dolan, R. T., Penny, S., Kelly, C. M., Brennan, D. J., Rexhepaj, E., Jirstrom, K., Ponten, F., Uhlen, M., Gallagher, W. M., and Kell, M. R (2011) 'Development of immunohistochemical surrogates for prediction of breast cancer patient outcome via high-throughput antibody generation and validation using tissue microarray technology' British Journal of Surgery . [Details]

Conference Publications

Dolan, R.T., Penny, S., Kelly, C.M., (Kelly, Brennan, D.J., Rexhepaj, E., Jirstrom, K., Ponten, F., Uhlen, M., Gallagher, W.M., Kell, M.R; (2011) Development of immunohistochemical surrogates for prediction of breast cancer patient outcome via high-throughput antibody generation and validation using tissue microarray technology The Annual Meeting of the Society of Academic and Research Surgery , pp.1-5 [Details]

Published Reports

Mitchell Barry; (2009) Nodal status in the era on sentinel node biopsy in Ireland. ASCO, ASCO. [Details]
 

Editorial

Kell, MR,Burke, JP; (2007) Management of breast cancer in women with BRCA gene mutation - Breast conservation surgery is safe in selected women when combined with adjuvant therapy. Editorial [DOI] [Details]
                 

Abstract

Walsh, E,Farrell, M,Clarke, R,Nolan, C,Kennedy, MJ,McCaffrey, JA,Connolly, E,Kell, M,Boyle, T,Gallagher, D (2012) BREAST CANCER DETECTION AMONG IRISH BRCA1 & BRCA2 MUTATION CARRIERS. Abstract [Details]
O'Reilly, EA,Furlong, F,Salman, R,Bambury, R,Harrison, M,Drew, G,Kelly, C,O'Grady, A,Kay, E,McCann, A,Kell, M (2012) Senescent and Autophagic cellular fates predict chemoresponse in TNBC. Abstract [Details]
Dolan, RT,Butler, JS,Kell, MR,Gorey, TF,Stokes, MA (2011) Nipple discharge and the efficacy of duct cytology in evaluating breast cancer risk. Abstract [Details]
Dolan, RT,Penny, S,Kelly, CM,Brennan, DJ,Rexhepaj, E,Jirstrom, K,Ponten, F,Uhlen, M,Gallagher, WM,Kell, MR (2011) Development of immunohistochemical surrogates for prediction of breast cancer patient outcome via high-throughput antibody generation and validation using tissue microarray technology. Abstract [Details]
Dolan, R,Kelly, C,Brennan, D,Ponten, F,Gallagher, W,Kell, M (2011) Novel prognostic immunohistochemical biomarker panel for breast cancer via high-throughput antibody generation and application of tissue microarray technology. Abstract [Details]
Calamai, A,Salman, R,Kennedy, M,Flanagan, F,Gorey, T,Kell, M,Stokes, M (2010) COLUMNAR CELL LESIONS OF THE BREAST: A 5 YEARS EXPERIENCE OF A BREAST UNIT. Abstract [Details]
Moran, C,Kell, MR,Flanagan, F,Kennedy, M,Corrigan, T,Gorey, T,Kerin, MJ (2004) Prophylactic sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients. Abstract [Details]
Kell, MR,Beddy, D,O'Toole, PJ,Conneely, J,Winter, DC,Watson, W,Fitzpatrick, JM,Kerin, M (2004) Systemic T cell interleukin 2 production correlates with disease stage in breast cancer patients. Abstract [Details]
Kell, MR,Beddy, D,Conneely, J,O'Toole, PJ,Winter, DC,Watson, W,Fitzpatrick, JM,Kerin, MJ (2003) T-cell function correlates with oncological status and disease stage in breast cancer. Abstract [Details]
Kell, MR,Sweeney, K,Beddy, D,Connelly, J,Winter, DC,Watson, RGW,Fitzpatrick, JM,Kerin, M (2003) Systemic T-cells are primed for a tumour permissive phenotype in breast cancer patients. Abstract [Details]
                                                             

Letters

Kell, MR (2009) In Response. Letters [DOI] [Details]
Kell, MR,Power, CP (2005) Adjuvant trastuzumab for breast cancer - Assessing HER2/neu status incurs more costs for treatment. Letters [Details]

Research

Research Interests

I am interested in surgical outcomes in cancer patients. Specifically melanoma and breast cancer.
Triple negative breast cancer. 
outcome following breast reconstruction. 
 

Research Projects

Sponsor : The Mater Foundation
Title : Exosome-mediated transfer of senescence signals in the tumour microenvironment (TME): A mechanism for propagating survival in the face of chemotherapy.
Start Date / End Date : 02-JUL-12 / 01-OCT-14
Sponsor : The Mater Foundation
Title : Exosome-mediated transfer of senescence signals in the tumour microenvironment (TME): A mechanism for propagating survival in the face of chemotherapy.
Start Date / End Date : 01-JUL-13 / 11-APR-16
Sponsor : Health Research Board (HRB)
Title : Preventing chemotherapy resistance in triple negative breast cancer
Start Date / End Date : 01-OCT-14 / 30-SEP-17
   

Collaborators

Internal Collaborators

Professor William Gallagher, Conway Institute, Dublin.
Dr Amanda McCann, Conway Institute, Dublin.

External Collaborators

Dr Monica Morrow, Memorial Sloane Ketterin cancer center, New York, USA